VEGF promotes CRC growth through the stimulation of angiogenesis and its downstream signaling pathways are well characterized in cancer, with VEGF/VEGFR activation leading to the activation of MAPK/ERK, PI3K/Akt, PLC/PKC and other signaling pathways [114,115] . The gene discussed is HSPG2; the disease is cancer.